Jiangsu Liansheng Pharmaceutical Co., Ltd.--Benzene ring derivative|Pyridine derivative|Other fine chemicals|IM-antiviral drug intermediate|IM-antitumor drugs intermediate|IM-other bulk drug intermediate|API-antiviral drug|API-antitumor drug|API-other bulk drug

<strike id="v053f"><input id="v053f"></input></strike>

<progress id="v053f"><input id="v053f"><s id="v053f"></s></input></progress>

<strike id="v053f"></strike>

<object id="v053f"><bdo id="v053f"></bdo></object>

<samp id="v053f"></samp>

<label id="v053f"><sub id="v053f"><font id="v053f"></font></sub></label>

<sub id="v053f"><meter id="v053f"></meter></sub>

◆ Characteristic key products >>More

◆ Key products >>More

Erlotinib Hydrochloride

	Allyrise: CPHI 2017 on Shanghai has successfully concluded	2017-06-27
	CPHI Europe 2017 on Oct. 20-22 (Allyrise: 6.1B73)	2017-05-24
	CPHI China 2017 on JUN. 20-22 (Allyrise:W4A50)	2017-05-24
	Congratulations to Allyrise: passing the ISO 9001:2015 Quality Management Syste	2017-05-22

4 Records

Home | About us | Products | Equipment | Order | Contact us | 中文版
Copyright(C)2013,Jiangsu Liansheng Pharmaceutical Co., Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice

點擊這里給我發消息

av熟女乱一区二区三区四区

<strike id="v053f"><input id="v053f"></input></strike>

<progress id="v053f"><input id="v053f"><s id="v053f"></s></input></progress>

<strike id="v053f"></strike>

<object id="v053f"><bdo id="v053f"></bdo></object>

<samp id="v053f"></samp>

<label id="v053f"><sub id="v053f"><font id="v053f"></font></sub></label>

<sub id="v053f"><meter id="v053f"></meter></sub>